Carbonnelle Amélie, Martin-Garcia Nadine, Ortonne Nicolas, Laroche Liliane, Bagot Martine, Molinier-Frenkel Valérie, Wechsler Janine
Département de Pathologie, Hôpital Henri Mondor, VI AP-HP, Université Paris XII, Créteil, France.
Virchows Arch. 2007 Apr;450(4):441-7. doi: 10.1007/s00428-007-0372-0. Epub 2007 Feb 15.
Distinguishing between low-grade primary cutaneous B-cell lymphoma (LG-pCBCL) and cutaneous lymphoid hyperplasia (CLH) based on histological features is often difficult. CLH lesions contain numerous reactive cells of the histiocyte lineage [Langerhans cells (LC), dermal dendritic cells (DDC), and macrophages], which are also often present in CBCL. The aim of this study was to determine whether immunohistochemical detection of those cells could help differentiate between CLH and LG-pCBCL. We determined the percentages of those histiocytic cells in the dermal infiltrates of 45 cases of cutaneous lymphoproliferations comprising 16 CLH and 29 LG-pCBCL (19 follicle-center cell lymphomas and 10 marginal zone lymphomas) by immunohistochemical labeling with antibodies to CD1a, FXIIIa, and CD68 to respectively detect LC, DDC, and macrophages. To avoid observer-dependent bias, an automated morphometric analysis method was used to recognize immunoreactive cells and calculate their percentages within the infiltrate. FXIIIa(+) cells were significatively more frequent in CLH than in LG-pCBCL, whereas CD1a(+) and CD68(+) cell frequencies were comparable in the two groups. The results of our study suggest that DDC might play an important role in the genesis of cutaneous lymphomas.
基于组织学特征区分低度原发性皮肤B细胞淋巴瘤(LG-pCBCL)和皮肤淋巴样增生(CLH)往往很困难。CLH病变包含许多组织细胞谱系的反应性细胞[朗格汉斯细胞(LC)、真皮树突状细胞(DDC)和巨噬细胞],这些细胞在CBCL中也常常存在。本研究的目的是确定对这些细胞进行免疫组化检测是否有助于区分CLH和LG-pCBCL。我们通过用抗CD1a、FXIIIa和CD68抗体进行免疫组化标记,分别检测LC、DDC和巨噬细胞,确定了45例皮肤淋巴增殖性疾病(包括16例CLH和29例LG-pCBCL,其中19例滤泡中心细胞淋巴瘤和10例边缘区淋巴瘤)真皮浸润中这些组织细胞的百分比。为避免观察者依赖性偏差,采用自动形态计量分析方法识别免疫反应性细胞并计算其在浸润中的百分比。FXIIIa(+)细胞在CLH中比在LG-pCBCL中明显更常见,而CD1a(+)和CD68(+)细胞频率在两组中相当。我们的研究结果表明,DDC可能在皮肤淋巴瘤的发生中起重要作用。